| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014262 |
| Receipt No. | R000016611 |
| Scientific Title | Investigation of dexmedetomidine concentration in breast milk during postpartum period |
| Date of disclosure of the study information | 2014/06/13 |
| Last modified on | 2021/04/19 (Ver. 5) |
| Basic information | ||
| Public title | Investigation of dexmedetomidine concentration in breast milk during postpartum period | |
| Acronym | Investigation of dexmedetomidine concentration in breast milk during postpartum period | |
| Scientific Title | Investigation of dexmedetomidine concentration in breast milk during postpartum period | |
| Scientific Title:Acronym | Investigation of dexmedetomidine concentration in breast milk during postpartum period | |
| Region |
|
|
| Condition | |||
| Condition | pregnant women undergo elective cesarean section | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To estimate the transfer of dexmedetomidine into breast milk after cesarean section |
| Basic objectives2 | Pharmacokinetics |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | dexmedetomidine concentration in breast milk |
| Key secondary outcomes | dexmedetomidine concentration in blood
neonatal assessment |
| Base | |
| Study type | |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | regulatory administration of dexmedetomidine after delivery for cesarean section | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | normal pregnant women undergo elective cesarean section | |||
| Key exclusion criteria | patientrefusal
serious preexisting condition massive bleeding unexpected vital change |
|||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tokuyama Central hospital | ||||||
| Division name | department of anesthesiology | ||||||
| Zip code | |||||||
| Address | 1-1 kodacyo, Shunan 745-8522, Japan | ||||||
| TEL | 0834-28-4411 | ||||||
| manabu-ygc@umin.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tokuyama Central Hospital | ||||||
| Division name | department of anesthesiology | ||||||
| Zip code | |||||||
| Address | 1-1 Kodacyo, Shunan 745-8522, Japan | ||||||
| TEL | 0834-28-4411 | ||||||
| Homepage URL | |||||||
| chiken2@tokuchuhp.jp | |||||||
| Sponsor | |
| Institute | Tokuyama Central Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tokuyama Central Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016611 |